Big Pharma Q2 2015 Financial Results Wrap Up

In the following table, the top pharma companies (by 2014 annual sales) key stats for Q2 2015.

Currency  Q2 2015 sales
(bn)
Growth yoy
(CER)
 Q2 2015 operating profit (bn) Op Margin (%) Publication date
1 Novartis USD 12.69 6.0% 2.28 18.0% 21.07.2015
2 Pfizer USD 11.85 -7.0% 3.68 31.1% 28.07.2015
3 Roche CHF 11.75 7.0% 3.86 32.8% 23.07.2015
4 Sanofi EUR  9.38 4.9% 2.57 27.4% 30.07.2015
5 Merck & Co. USD 9.79 -11.0% 1.74 17.8% 28.07.2015
6 Johnson & Johnson USD 17.79 -8.8% 4.92 27.6% 14.07.2015
7 GlaxoSmithKline GBP 5.89 7.0% 1.35 22.9% 29.07.2015
8 AstraZeneca GBP 6.31 2.0% 1.81 28.7% 30.07.2015
9 Gilead Sciences USD 8.13 26.1% 5.62 69.1% 28.07.2015
10 Takeda JPY 446.30 6.1% 49.60 11.1% 30.07.2015
11 AbbVie USD 5.48 19.4% 1.85 33.8% 24.07.2015
12 Amgen USD 5.37 4.0% 2.08 38.7% 30.07.2015
13 Teva USD 4.97 -2.0% 1.61 32.4% 30.07.2015
14 Lilly USD 4.98 1.0% 0.80 16.1% 23.07.2015
15 Bristol-Myers Squibb USD 4.16 7.0% 0.05 1.2% 23.07.2015
16 Bayer Healthcare EUR 5.91 28.0% 0.95 16.1% 29.07.2015
17 Novo Nordisk DKK 27.06  25.0%  12.48  46.1% 06.08.2015
18 Astellas JPY 343.66 16.4% 67.82 19.7% 31.07.2015
19 Allergan
(former Actavis)
USD 5.73 Undisclosed  2.50 43.6% 05.08.2015

Notes:

– For Roche the operating profit figure is an estimate as the company only published sales for Q1.

– It should be named Q1 for Japanese companies as the majority of them has a fiscal year ending in March.

Image Source

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s